Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant bias » significant based (Expand Search), significant gap (Expand Search), significant degs (Expand Search)
bias decrease » sizes decrease (Expand Search), bias increases (Expand Search), mean decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant bias » significant based (Expand Search), significant gap (Expand Search), significant degs (Expand Search)
bias decrease » sizes decrease (Expand Search), bias increases (Expand Search), mean decrease (Expand Search)
-
1961
-
1962
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
1963
-
1964
-
1965
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
1966
-
1967
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
1968
-
1969
-
1970
-
1971
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
1972
-
1973
-
1974
-
1975
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
1976
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
1977
-
1978
-
1979
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
1980